Back to search
FDAFDA · Food and drugs·Recall number D-0683-2018

Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc. Amityville, NY 11701 for Leadiant Biosciences, Inc. Gaithersburg, MD 20878, NDC 54482-020-01

Published April 25, 2018 · Recall initiated: April 9, 2018

Summary

FDA records drug Class III recall D-0683-2018, published April 25, 2018 and initiated April 9, 2018. Recalling firm: LEADIANT BIOSCIENCES, INC; Status: Terminated; Reported quantity: 3,398 bottles; Lot: lot numbers: 35866, Exp 6/18; 358663, Exp 7/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.

What to do

Voluntary: Firm initiated · Letter

Get an email if CYSTARAN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CYSTARAN
Manufacturer
LEADIANT BIOSCIENCES, INC
Distributor
Walgreens Specialty Pharmacy Pittsburg, PA Italy and Germany
Lot
lot numbers: 35866, Exp 6/18; 358663, Exp 7/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc. Amityville, NY 11701 for Leadiant Biosciences, Inc. Gaithersburg, MD 20878, NDC 54482-020-01 recalled?

Yes. FDA published recall D-0683-2018 on April 25, 2018. Reported hazard: Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CYSTARAN.